Table I.
Clinicopathologic featurea | Cases n=84 | VEGF expression
|
TP expression
|
MVD
|
||||||
---|---|---|---|---|---|---|---|---|---|---|
High (n=53) |
Low (n=31) |
P-value | High (n=55) |
Low (n=29) |
P-value | High (n=39) |
Low (n=45) |
P-value | ||
Gender | 0.27 | 0.15 | 0.11 | |||||||
Male | 55 | 37 | 18 | 33 | 22 | 29 | 26 | |||
Female | 29 | 16 | 13 | 22 | 7 | 10 | 19 | |||
Location | 0.77 | 0.57 | 0.72 | |||||||
Colon | 47 | 29 | 18 | 32 | 15 | 21 | 26 | |||
Rectum | 37 | 24 | 13 | 23 | 14 | 18 | 19 | |||
Histological type | 0.25 | 0.21 | 0.11 | |||||||
Well | 35 | 24 | 11 | 23 | 12 | 21 | 14 | |||
Moderate | 43 | 27 | 16 | 30 | 13 | 16 | 27 | |||
Poor/Other | 6 | 2 | 4 | 2 | 4 | 2 | 4 | |||
Lymph node metastasis | 0.13 | 0.84 | 0.15 | |||||||
pN0 | 36 | 26 | 10 | 24 | 12 | 20 | 16 | |||
pN1–4 | 48 | 27 | 21 | 31 | 17 | 19 | 29 | |||
Lymphatic invasion | 0.78 | 0.81 | 0.63 | |||||||
ly0–1 | 45 | 29 | 16 | 30 | 15 | 22 | 23 | |||
ly2–3 | 39 | 24 | 15 | 25 | 14 | 17 | 22 | |||
Venous invasion | 0.57 | 0.76 | 0.37 | |||||||
v0–1 | 62 | 38 | 24 | 40 | 22 | 27 | 35 | |||
v2–3 | 22 | 15 | 7 | 15 | 7 | 12 | 10 | |||
Budding | 0.88 | 0.41 | 0.21 | |||||||
Grade 0–1 | 47 | 30 | 17 | 29 | 18 | 19 | 28 | |||
Grade 2–3 | 37 | 23 | 14 | 26 | 11 | 20 | 17 | |||
Dukes' stage | 0.49 | 0.58 | 0.047b | |||||||
A | 8 | 6 | 2 | 7 | 1 | 7 | 1 | |||
B | 26 | 18 | 8 | 16 | 10 | 13 | 13 | |||
C | 27 | 14 | 13 | 17 | 10 | 12 | 15 | |||
D | 23 | 15 | 8 | 15 | 8 | 7 | 16 |